Advertisement
Advertisement

HALO

HALO logo

Halozyme Therapeutics, Inc.

65.14
USD
Sponsored
+0.85
+1.32%
Mar 17, 16:00 UTC -4
Closed
exchange

After-Market

65.64

+0.50
+0.77%

Halozyme Therapeutics, Inc. Financial Snapshot

Market Cap
7.75B
Beta
0.98
Earnings Per Share (EPS)
2.49
Price-to-Book (P/B) Ratio
153.36
Operating Margin
33.33%
Total Debt/Equity (D/E)
4389.38%
P/E Ratio
16.84
Return on Equity (ROE)
136.12%
Current Ratio
4.66%
Free Cash Flow
644.59M

Earnings Chart

Trending Stocks

Advertisement